Page last updated: 2024-10-25

deferiprone and Pseudoxanthoma Elasticum

deferiprone has been researched along with Pseudoxanthoma Elasticum in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Pseudoxanthoma Elasticum: An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noureldine, MHA1
Taher, AT1
Haydar, AA1
Berjawi, A1
Khamashta, MA1
Uthman, I1

Reviews

1 review available for deferiprone and Pseudoxanthoma Elasticum

ArticleYear
Rheumatological complications of beta-thalassaemia: an overview.
    Rheumatology (Oxford, England), 2018, 01-01, Volume: 57, Issue:1

    Topics: Arthritis; beta-Thalassemia; Blood Transfusion; Connective Tissue Diseases; Deferiprone; Femur Head

2018